MicroRNAs |
MiR-375 inhibition |
activation |
ADAMTS-5↓, MMP-13↓, COL-II↑, AGG↑, p-JAK2/JAK2↑, p-STAT3/STAT3↑, Bcl-2/Bax↑ |
Improved the ability of chondrocytes to antagonize oxidative stress and maintain ECM homeostasis |
[28, 67] |
|
MiR-149-5p |
Inhibition |
AGT↓, ANGII, AT1R |
Regulated and combined AGT, promoted the inflammatory responses induced by IL-6 |
[39] |
|
MiR-216a-5p |
Inhibition |
Bax↓, Caspase-3↓, Bcl-2↑ |
Promoted the proliferation and migrations well as inhibited apoptosis in chondrocytes |
[29] |
|
MiR-224-5p |
Inhibition |
MMP-9↓, MMP-13↓, COL-II↑, AGG↑, Caspase-3↓, Circ_PDE1C↓ |
Inhibited chondrocytes apoptosis and ECM degradation. Targeted CCL2 and accelerated cartilage degradation |
[44] |
Traditional Chinese medicine |
Danshen |
activation |
P-JAK2, p-STAT3↓, GSH, SOD, CAT↑, Bcl-2↑, Bax, caspase3, PARP↓ |
Attenuated cartilage injuries by activating JAK2/STAT3 pathway |
[71] |
|
Diosgenin |
activation |
P-JAK2, p-STAT3, SDH, COX, SOD↑, Bax↓ |
Protected OA cartilage cells by activating the JAK2/STAT3 pathway, which effectively reduces mitochondrial oxidative stress damage and apoptosis in OA cells during the pathological process |
[73] |
|
curcumin |
activation |
P-JAK2, p-STAT3, |
Increased the mitochondrial resistance to oxidative stress in chondrocytes, significantly slows down the degeneration of articular cartilage, and reduces the level of OA progression |
[75] |
|
Resveratrol |
Inhibition |
JAK2, STAT3, SOCS3, MMP-13↓ |
No significant leptin resistance existed in articular cartilage of obesity-related OA and the inhibitory effect of RES on obesity-related OA via alleviating JAK2/STAT3 signaling pathway |
[77] |
Inhibitors |
AG490 |
Inhibition |
JAK2↓ |
Inhibited JAK2/STAT3 activation and apoptosis in chondrocytes induced by IL-1β |
[62, 79] |
|
WP1066 |
Inhibition |
JAK2, STAT3↓ |
Downregulated the expression of JAK2/STAT3 to suppress the chondrocytic inflammation responses induced by IL-6 |
[39] |
|
Tofacitinibis |
Inhibition |
JAK, STAT3↓ |
Moderated chondrogenic hypertrophy in human chondrocyte lines via downregulation of JAK/STAT3 |
[68] |
|
Pranlukast |
Inhibition |
JAK2, STAT1↓ |
Reversed the enhancement levels of pro-inflammatory cytokines to prevent the progression of OA |
[81] |
|
STA21 |
Inhibition |
STAT3↓ |
Blocked STAT3 dimerization and DNA binding to alleviate joint pain and cartilage damage |
[82] |
|
Stattic |
Inhibition |
STAT3↓ |
Reduced the severity of OA cartilage lesions and decreased the size of osteophytes. Stattic had no significant effect on the synovium or the subchondral bone |
[55] |